Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoprotein

被引：0
|
作者：
Faisal Alotaibi
机构：
[1] Shaqra University,Department of Pharmacy Practice, College of Pharmacy
来源：
Future Journal of Pharmaceutical Sciences | / 9卷
关键词：
Ranolazine; Naringenin; Pharmacokinetics; Drug-drug interaction; Area under the curve (AUC); CYP3A4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Naringenin alters the pharmacokinetics of ranolazine in part through the inhibition of cytochrome P450 (3A4) and P-glycoprotein
    Alotaibi, Faisal
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 9 (01)
  • [2] An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic
    Foster, BC
    Foster, MS
    Vandenhoek, S
    Krantis, A
    Budzinski, JW
    Arnason, JT
    Gallicano, KD
    Choudri, S
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2001, 4 (02): : 176 - 184
  • [3] Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
    Engels, FK
    ten Tije, AJ
    Baker, SD
    Lee, CKK
    Loos, WJ
    Vulto, AG
    Verweij, J
    Sparreboom, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (05) : 448 - 454
  • [4] Effect of Leech Lime Juice on Cytochrome P450 3A4 and P-Glycoprotein Activities
    Piyapolrungroj, Nusara
    Sotanaphun, Uthai
    Phattanawasin, Panadda
    DRUG METABOLISM REVIEWS, 2009, 41 : 101 - 101
  • [5] Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4
    Aneta Doricakova
    Dirk Theile
    Johanna Weiss
    Radim Vrzal
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 49 - 59
  • [6] Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P450 3A4
    Achira, M
    Suzuki, H
    Ito, K
    Sugiyama, Y
    AAPS PHARMSCI, 1999, 1 (04):
  • [7] Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazoly/penicillin antibiotic flucloxacillin
    Huwyler, J
    Wright, MB
    Gutmann, H
    Drewe, J
    CURRENT DRUG METABOLISM, 2006, 7 (02) : 119 - 126
  • [8] Differential effects of the enantiomers of tamsulosin and tolterodine on P-glycoprotein and cytochrome P450 3A4
    Doricakova, Aneta
    Theile, Dirk
    Weiss, Johanna
    Vrzal, Radim
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (01) : 49 - 59
  • [9] Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4
    Takanaga, H
    Ohnishi, A
    Yamada, S
    Matsuo, H
    Morimoto, S
    Shoyama, Y
    Ohtani, H
    Sawada, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 293 (01): : 230 - 236
  • [10] Furanocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-Glycoprotein
    Iwanaga, Kazunori
    Hayashi, Manami
    Hamahata, Yukimi
    Miyazaki, Makoto
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Kakemi, Masawo
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) : 1286 - 1294
12345